BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33527196)

  • 1. CD30
    Lam JH; Hong M; Koo SL; Chua CWL; Lim KL; Wee F; Wan WK; Leow WQ; Yeo JG; Tan IBH; Yeong J; Lim TKH; Lim TS
    Cancer Immunol Immunother; 2021 Aug; 70(8):2353-2365. PubMed ID: 33527196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen-specific Tregs control T cell responses against a limited repertoire of tumor antigens in patients with colorectal carcinoma.
    Bonertz A; Weitz J; Pietsch DH; Rahbari NN; Schlude C; Ge Y; Juenger S; Vlodavsky I; Khazaie K; Jaeger D; Reissfelder C; Antolovic D; Aigner M; Koch M; Beckhove P
    J Clin Invest; 2009 Nov; 119(11):3311-21. PubMed ID: 19809157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic depletion of CCR8
    Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTLA-4 blockade drives loss of T
    Zappasodi R; Serganova I; Cohen IJ; Maeda M; Shindo M; Senbabaoglu Y; Watson MJ; Leftin A; Maniyar R; Verma S; Lubin M; Ko M; Mane MM; Zhong H; Liu C; Ghosh A; Abu-Akeel M; Ackerstaff E; Koutcher JA; Ho PC; Delgoffe GM; Blasberg R; Wolchok JD; Merghoub T
    Nature; 2021 Mar; 591(7851):652-658. PubMed ID: 33588426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer.
    Martinez M; Kim S; St Jean N; O'Brien S; Lian L; Sun J; Verona RI; Moon E
    Oncoimmunology; 2021 Jan; 10(1):1873607. PubMed ID: 33537176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of storage time and temperature on highly multiparametric flow analysis of peripheral blood samples; implications for clinical trial samples.
    Jerram A; Guy TV; Beutler L; Gunasegaran B; Sluyter R; Fazekas de St Groth B; McGuire HM
    Biosci Rep; 2021 Feb; 41(2):. PubMed ID: 33600563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models.
    Goto S; Sakoda Y; Adachi K; Sekido Y; Yano S; Eto M; Tamada K
    Cancer Immunol Immunother; 2021 Sep; 70(9):2503-2515. PubMed ID: 33559069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies.
    Song Z; Wang M; Ge Y; Chen XP; Xu Z; Sun Y; Xiong XF
    Acta Pharm Sin B; 2021 Jan; 11(1):13-29. PubMed ID: 33532178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells.
    Duhen R; Ballesteros-Merino C; Frye AK; Tran E; Rajamanickam V; Chang SC; Koguchi Y; Bifulco CB; Bernard B; Leidner RS; Curti BD; Fox BA; Urba WJ; Bell RB; Weinberg AD
    Nat Commun; 2021 Feb; 12(1):1047. PubMed ID: 33594075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR8 Signaling
    Kang L; Schmalzl A; Leupold T; Gonzalez-Acera M; Atreya R; Neurath MF; Becker C; Wirtz S
    Front Immunol; 2020; 11():609400. PubMed ID: 33613532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study.
    Huang L; Zhang X; Bai Y; Chua KLM; Xie Y; Shu X; Long B; Fan C; Lim DWT; Tan SH; Wee JTS; Wang Y; Wu Y; Chua MLK
    Oral Oncol; 2021 Apr; 115():105222. PubMed ID: 33610004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma.
    Xu JZ; Gong C; Xie ZF; Zhao H
    Front Oncol; 2020; 10():593022. PubMed ID: 33585210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CC Chemokine Receptors in Lung Adenocarcinoma: The Inflammation-Related Prognostic Biomarkers and Immunotherapeutic Targets.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():267-285. PubMed ID: 33574689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided design of PVR mutants with enhanced binding affinity to TIGIT.
    Zhou X; Du J; Zhou X; Niu X; Li W; Chen C; Lv S; Wu A; Gou S; Sun Y; Zhai W; Qiu L; Qi Y; Zhao W; Gao Y
    Cell Commun Signal; 2021 Feb; 19(1):12. PubMed ID: 33557880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fc-Optimized Anti-CCR8 Antibody Depletes Regulatory T Cells in Human Tumor Models.
    Campbell JR; McDonald BR; Mesko PB; Siemers NO; Singh PB; Selby M; Sproul TW; Korman AJ; Vlach LM; Houser J; Sambanthamoorthy S; Lu K; Hatcher SV; Lohre J; Jain R; Lan RY
    Cancer Res; 2021 Jun; 81(11):2983-2994. PubMed ID: 33757978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systems biology analysis identifies
    Cho JW; Son J; Ha SJ; Lee I
    Comput Struct Biotechnol J; 2021; 19():860-868. PubMed ID: 33598101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
    Cappell KM; Kochenderfer JN
    Nat Rev Clin Oncol; 2021 Nov; 18(11):715-727. PubMed ID: 34230645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To Go or Not to Go?-Targeting Tregs Traveling in Tumors.
    Chakraborty S; Zappasodi R
    Cancer Res; 2021 Jun; 81(11):2817-2819. PubMed ID: 34087782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR8 marks highly suppressive Treg cells within tumours but is dispensable for their accumulation and suppressive function.
    Whiteside SK; Grant FM; Gyori DS; Conti AG; Imianowski CJ; Kuo P; Nasrallah R; Sadiyah F; Lira SA; Tacke F; Eil RL; Burton OT; Dooley J; Liston A; Okkenhaug K; Yang J; Roychoudhuri R
    Immunology; 2021 Aug; 163(4):512-520. PubMed ID: 33838058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.